Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Muscle Contraction

dichlororibofuranosylbenzimidazole has been researched along with Muscle Contraction in 2 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tolloczko, B1
Turkewitsch, P1
Al-Chalabi, M1
Martin, JG1
Prieto, D1
Buus, C1
Mulvany, MJ1
Nilsson, H1

Other Studies

2 other studies available for dichlororibofuranosylbenzimidazole and Muscle Contraction

ArticleYear
LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 311, Issue:2

    Topics: Androstadienes; Animals; Bronchi; Calcium; Calcium Signaling; Chromones; Dichlororibofuranosylbenzim

2004
Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential.
    The Journal of physiology, 1997, Jul-15, Volume: 502 ( Pt 2)

    Topics: 4-Aminopyridine; Acetylcholine; Adenylyl Cyclases; Animals; Charybdotoxin; Colforsin; Cyclic AMP-Dep

1997